Bionano Genomics (BNGO) Change in Cash (2017 - 2026)

Bionano Genomics has disclosed Change in Cash across 10 years of filings, most recently posting $403000.0 for Q1 2026.

• Change in Cash for Q1 2026 came in at $403000.0, up 106.78% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 million (up 110.27% YoY), and the FY2025 annual result was -$5.1 million, up 42.29% from the prior year.
• Change in Cash came in at $403000.0 for Q1 2026 at Bionano Genomics, down from $1.4 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $19.7 million in Q3 2023 to a low of -$22.7 million in Q4 2022.
• The 5-year median for Change in Cash is -$63000.0 (2025), against an average of -$1.2 million.
• Across the five-year window, Change in Cash soared 1857.5% in 2023 and sank 171.72% in 2025, its largest moves.
• Bionano Genomics' Change in Cash stood at -$22.7 million in 2022, then rose by 26.7% to -$16.6 million in 2023, then jumped by 102.28% to $379000.0 in 2024, then jumped by 281.0% to $1.4 million in 2025, then plunged by 72.09% to $403000.0 in 2026.
• The last three Change in Cash figures came in at $403000.0 (Q1 2026), $1.4 million (Q4 2025), and -$497000.0 (Q3 2025), per Business Quant data.